Meng Xie

810 total citations
21 papers, 459 citations indexed

About

Meng Xie is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Meng Xie has authored 21 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Meng Xie's work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (3 papers) and Immune cells in cancer (3 papers). Meng Xie is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (3 papers) and Immune cells in cancer (3 papers). Meng Xie collaborates with scholars based in China, United Kingdom and Ethiopia. Meng Xie's co-authors include Limin Xia, Wenjie Huang, Mengyu Sun, Tongyue Zhang, Yijun Wang, Danfei Liu, Xiaoyu Ji, Bixiang Zhang, Jiafu Ji and Xiaoping Chen and has published in prestigious journals such as Hepatology, Frontiers in Immunology and Cell Death and Disease.

In The Last Decade

Meng Xie

18 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meng Xie China 11 282 205 127 100 95 21 459
Ruiqing Peng China 12 293 1.0× 183 0.9× 160 1.3× 99 1.0× 79 0.8× 27 503
Na Zhou China 14 266 0.9× 223 1.1× 156 1.2× 99 1.0× 55 0.6× 33 488
Zhiying Zheng China 8 235 0.8× 176 0.9× 143 1.1× 146 1.5× 164 1.7× 15 439
Shunli Peng China 9 234 0.8× 168 0.8× 194 1.5× 76 0.8× 139 1.5× 14 451
Bo Ni China 12 282 1.0× 218 1.1× 128 1.0× 163 1.6× 116 1.2× 30 560
Chun‐Hua Wang China 14 223 0.8× 129 0.6× 126 1.0× 72 0.7× 49 0.5× 20 413
Ya-Ming Meng China 8 200 0.7× 115 0.6× 152 1.2× 127 1.3× 55 0.6× 10 404
Hongjuan Xu China 9 233 0.8× 155 0.8× 88 0.7× 61 0.6× 68 0.7× 21 372
Zhuqing Zhou China 14 329 1.2× 205 1.0× 150 1.2× 66 0.7× 97 1.0× 26 529
Tinghua Hu China 12 280 1.0× 148 0.7× 138 1.1× 76 0.8× 67 0.7× 35 461

Countries citing papers authored by Meng Xie

Since Specialization
Citations

This map shows the geographic impact of Meng Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Xie more than expected).

Fields of papers citing papers by Meng Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Xie. The network helps show where Meng Xie may publish in the future.

Co-authorship network of co-authors of Meng Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Xie. A scholar is included among the top collaborators of Meng Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Xie. Meng Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Meng, et al.. (2024). Rapid progress of an iris metastasis from esophageal cancer: a case report and review of literature. International Journal of Ophthalmology. 17(8). 1557–1567.
2.
Xie, Meng, et al.. (2024). Vessel co-option: a unique vascular-immune niche in liver cancer. Frontiers in Oncology. 14. 1386772–1386772. 5 indexed citations
3.
Sun, Mengyu, Weibo Feng, Jie Chen, et al.. (2023). An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma. Frontiers in Genetics. 14. 1056000–1056000. 8 indexed citations
4.
Hu, Haoyue, Meng Xie, Peng Guo, et al.. (2023). Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer. Frontiers in Pharmacology. 14. 1167959–1167959. 2 indexed citations
5.
6.
Wang, Yi‐Jun, Mengyu Sun, Tongyue Zhang, et al.. (2022). Role of chemokines in the hepatocellular carcinoma microenvironment and their translational value in immunotherapy*. Oncology and Translational Medicine. 8(1). 1–17. 1 indexed citations
7.
Sun, Mengyu, Xiaoyu Ji, Meng Xie, et al.. (2022). Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer. Frontiers in Immunology. 13. 999084–999084. 6 indexed citations
8.
Zhang, Tongyue, Yijun Wang, Meng Xie, et al.. (2022). HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET. Journal of Experimental & Clinical Cancer Research. 41(1). 275–275. 27 indexed citations
9.
Xie, Meng, et al.. (2022). Submucosal Clustered Brownish Microvessels Based on NBI Endoscopy: A Characteristic of LPR. Otolaryngology. 168(4). 790–797. 1 indexed citations
10.
Luo, Xiangyuan, Xiaoyu Ji, Meng Xie, et al.. (2022). Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy. Cancers. 14(5). 1165–1165. 9 indexed citations
11.
12.
Qiao, Chenyang, Wenjie Huang, Jie Chen, et al.. (2021). IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R. Cell Death and Disease. 12(6). 564–564. 46 indexed citations
13.
Zhang, Qingqing, Meng Xie, Ruixin Guo, et al.. (2021). [Effect of proton pump inhibitort on salivary pepsin concentration in patients with laryngopharyngeal reflux].. PubMed. 35(11). 965–970. 2 indexed citations
14.
Wang, Yijun, Tongyue Zhang, Mengyu Sun, et al.. (2021). Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes. Cancers. 13(20). 5127–5127. 27 indexed citations
15.
Li, Dongxiao, et al.. (2020). CAMSAP2-mediated noncentrosomal microtubule acetylation drives hepatocellular carcinoma metastasis. Theranostics. 10(8). 3749–3766. 22 indexed citations
16.
Shi, Yewen, Qingqing Zhang, Meng Xie, et al.. (2020). Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT. Oncology Reports. 44(6). 2503–2516. 16 indexed citations
17.
Sun, Zhiwei, Xiangyu Gao, Catherine Zabkiewicz, et al.. (2020). Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR. International Journal of Oncology. 57(3). 813–824. 12 indexed citations
18.
Guo, Ting, Xianzi Wen, Ziyu Li, et al.. (2019). ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7. Cell Death and Disease. 10(2). 33–33. 37 indexed citations
19.
Xie, Meng, D. Alwyn Dart, Ting Guo, et al.. (2017). MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer. Gastric Cancer. 21(1). 41–54. 54 indexed citations
20.
Xie, Meng, D. Alwyn Dart, Sioned Owen, et al.. (2016). Insights into roles of the miR-1, -133 and -206 family in gastric cancer (Review). Oncology Reports. 36(3). 1191–1198. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruiqing Peng Breakdown of academic impact, for papers by Na Zhou Breakdown of academic impact, for papers by Zhiying Zheng Breakdown of academic impact, for papers by Shunli Peng Breakdown of academic impact, for papers by Bo Ni Breakdown of academic impact, for papers by Chun‐Hua Wang Breakdown of academic impact, for papers by Ya-Ming Meng Breakdown of academic impact, for papers by Hongjuan Xu Breakdown of academic impact, for papers by Zhuqing Zhou Breakdown of academic impact, for papers by Tinghua Hu
Rankless by CCL
2026